Page last updated: 2024-10-31

metoclopramide and Migraine with Aura

metoclopramide has been researched along with Migraine with Aura in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Migraine with Aura: A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rozen, TD1

Other Studies

1 other study available for metoclopramide and Migraine with Aura

ArticleYear
Migraine prodrome: a nose on a face.
    Lancet (London, England), 2004, Feb-14, Volume: 363, Issue:9408

    Topics: Adult; Dopamine Antagonists; Facies; Female; Flushing; Humans; Metoclopramide; Migraine with Aura; N

2004